Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 5377 - 5384 of 12092 results

What to Expect at FDA Following Commissioner Gottlieb's Departure
March 6, 2019| Blog| Viewpoint

Does the Physical or Mental Impairment of a Party Make An Arbitration Agreement Voidable?
March 5, 2019| Blog| Viewpoint

U.S. Supreme Court Holds That Copyrights Must Be Registered before Plaintiffs Can File Infringement Suits
March 5, 2019| Blog| Viewpoint

Mintz Lands 2nd Real Estate Lawyer From Mayer Brown
March 5, 2019| News

AHLA Health Care Compliance Legal Issues Manual
March 5, 2019| News

Five Takeaways from the Senate Finance Committee’s Hearing on Drug Pricing
March 4, 2019| Blog| Viewpoint

ML Strategies Health Care Preview - Week of March 4, 2019
March 4, 2019| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
